Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1167.10 -13.15 (-1.11%) | NSE 1172.70 -7.40 (-0.63%) | Trade | Add

BSE Live

Jan 16, 16:01

1167.10 -13.15 (-1.11%)

Volume

AVERAGE VOLUME

5-Day

15,253

10-Day

25,335

30-Day

23,438

13,331

Prev. Close

1180.25
Open Price

1171.55

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 16, 15:50

1172.70 -7.40 (-0.63%)

Volume

AVERAGE VOLUME

5-Day

807,805

10-Day

981,854

30-Day

802,605

909,022

Prev. Close

1180.10
Open Price

1174.20

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1172.70 (585)

Financials

Print/Copy to Excel : Go

Balance Sheet of Aurobindo Pharma (in Rs. Cr.)	Mar 10	Mar 09	Mar 08	Mar 07	Mar 06
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	27.86	26.88	26.88	26.67	26.63
Total Share Capital	27.86	26.88	26.88	26.67	26.63
Reserves and Surplus	1,886.50	1,293.95	1,193.72	902.63	878.78
Total Reserves and Surplus	1,886.50	1,293.95	1,193.72	902.63	878.78
Total Shareholders Funds	1,914.36	1,320.83	1,220.60	929.30	905.41
NON-CURRENT LIABILITIES
Long Term Borrowings	840.61	1,134.10	1,144.71	1,350.14	658.55
Deferred Tax Liabilities [Net]	111.11	97.13	92.04	86.79	94.43
Other Long Term Liabilities	0.00	0.00	0.00	0.00	0.00
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	951.72	1,231.23	1,236.75	1,436.93	752.98
CURRENT LIABILITIES
Short Term Borrowings	1,104.17	980.58	610.94	626.20	546.67
Trade Payables	514.27	415.11	403.65	314.80	267.93
Other Current Liabilities	94.56	82.78	10.37	8.05	16.60
Short Term Provisions	39.37	30.77	33.80	23.63	13.68
Total Current Liabilities	1,752.37	1,509.24	1,058.76	972.68	844.88
Total Capital And Liabilities	4,618.45	4,061.30	3,516.11	3,338.93	2,503.31
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,041.38	871.94	826.07	710.65	681.68
Intangible Assets	3.96	0.93	1.01	1.83	36.74
Capital Work-In-Progress	499.47	285.96	124.69	183.14	145.45
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	1,544.81	1,158.83	951.77	895.62	863.87
Non-Current Investments	379.24	277.74	290.04	202.73	174.16
Deferred Tax Assets [Net]	16.04	18.73	19.58	19.57	22.57
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	1,940.09	1,455.30	1,261.39	1,117.92	1,060.60
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	944.82	735.52	651.23	547.28	383.44
Trade Receivables	1,151.35	1,105.67	798.97	624.41	569.00
Cash And Cash Equivalents	4.56	86.94	239.32	500.07	142.07
Short Term Loans And Advances	576.29	677.87	565.20	549.25	348.20
OtherCurrentAssets	1.34	0.00	0.00	0.00	0.00
Total Current Assets	2,678.36	2,606.00	2,254.72	2,221.01	1,442.71
Total Assets	4,618.45	4,061.30	3,516.11	3,338.93	2,503.31
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	139.04	90.03	180.41	79.47	130.82
CIF VALUE OF IMPORTS
Raw Materials	1,251.77	1,187.30	1,018.34	948.79	667.71
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	77.02	67.62	19.38	38.18	29.21
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	58.99	55.38	69.87	52.06	31.65
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	2,086.37	1,746.65	1,339.50	1,096.83	816.33
Other Earnings	125.88	100.38	98.29	64.46	16.62
BONUS DETAILS
Bonus Equity Share Capital	17.35	17.35	17.35	17.35	17.35
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.05	0.02	0.03	0.03	0.04
Non-Current Investments Unquoted Book Value	370.87	269.39	287.92	202.70	174.12
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--